日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-Reported Outcomes Following UGN-102 Treatment in Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: An Analysis of 3 Clinical Trials

UGN-102治疗低级别中危非肌层浸润性膀胱癌的患者报告结局:3项临床试验的分析

Peyton, Charles C; Kates, Max; Nadkarni, Anagha; Dhanda, Rahul; Ugwuoke, Nikky; Tsurutis, Victoria; Burger, Brent; Lee, L Veronica; Louie, Michael J; Burke, Tom; Stover, Angela M

Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry

患者自述拒绝或停止他汀类药物治疗的原因:来自 PALM 注册研究的启示

Bradley, Corey K; Wang, Tracy Y; Li, Shuang; Robinson, Jennifer G; Roger, Veronique L; Goldberg, Anne C; Virani, Salim S; Louie, Michael J; Lee, L Veronica; Peterson, Eric D; Navar, Ann Marie

Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry)

临床医生知识和对他汀类药物的信念与他汀类药物治疗使用及血脂水平的关系(基于美国 PALM 注册中心的一项实践调查)

Lowenstern, Angela; Navar, Ann Marie; Li, Shuang; Virani, Salim S; Goldberg, Anne C; Louie, Michael J; Lee, L Veronica; Peterson, Eric D; Wang, Tracy Y

Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry

患者对心血管风险的认知和对斯他汀类药物的信念与他汀类药物使用中的种族差异之间的关联:来自患者和医护人员对血脂管理登记评估的见解

Nanna, Michael G; Navar, Ann Marie; Zakroysky, Pearl; Xiang, Qun; Goldberg, Anne C; Robinson, Jennifer; Roger, Veronique L; Virani, Salim S; Wilson, Peter W F; Elassal, Joseph; Lee, L Veronica; Wang, Tracy Y; Peterson, Eric D

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

75岁以上成年人使用他汀类药物及其不良反应:来自患者和医护人员脂质管理评估(PALM)注册研究的启示

Nanna, Michael G; Navar, Ann Marie; Wang, Tracy Y; Mi, Xiaojuan; Virani, Salim S; Louie, Michael J; Lee, L Veronica; Goldberg, Anne C; Roger, Veronique L; Robinson, Jennifer; Peterson, Eric D

Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials

治疗期间女性和男性低密度脂蛋白胆固醇降低及主要不良心血管事件:10项ODYSSEY 3期Alirocumab试验的汇总分析

Vallejo-Vaz, Antonio J; Ginsberg, Henry N; Davidson, Michael H; Eckel, Robert H; Cannon, Christopher P; Lee, L Veronica; Bessac, Laurence; Pordy, Robert; Letierce, Alexia; Ray, Kausik K

Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry

测量一级和二级预防患者低密度脂蛋白胆固醇水平:来自 PALM 注册研究的启示

Lowenstern, Angela M; Li, Shuang; Navar, Ann Marie; Roger, Veronique L; Robinson, Jennifer G; Goldberg, Anne C; Virani, Salim S; Lee, L Veronica; Wilson, Peter W F; Louie, Michael J; Peterson, Eric D; Wang, Tracy Y

Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry

临床医生报告的血脂指南采纳情况是否能转化为符合指南的治疗?一项基于患者和医护人员血脂管理评估(PALM)注册研究的评估

Lowenstern, Angela; Li, Shuang; Navar, Ann Marie; Virani, Salim; Lee, L Veronica; Louie, Michael J; Peterson, Eric D; Wang, Tracy Y

Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry

当代社区医疗实践中的血脂管理:来自血脂管理提供者评估(PALM)注册研究的结果

Navar, Ann Marie; Wang, Tracy Y; Li, Shuang; Robinson, Jennifer G; Goldberg, Anne C; Virani, Salim; Roger, Veronique L; Wilson, Peter W F; Elassal, Joseph; Lee, L Veronica; Peterson, Eric D

Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia

阿利西尤单抗剂量增加对血脂异常患者降低低密度脂蛋白胆固醇和达到血脂目标的影响

Kastelein, John J P; Kereiakes, Dean J; Cannon, Christopher P; Bays, Harold E; Minini, Pascal; Lee, L Veronica; Maroni, Jaman; Farnier, Michel